The presence of high glucose significantly increased p38 MAPK signaling and escalated cardiac hypertrophy induced by hyperglycemia, whereas miR-373 inhibits MEF-2 activity by down regulating p38 signaling and reducing glucose induced hypertrophy [113]. Here, MEF2A is linked to cardiac hypertrophy.